These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 1838609)

  • 1. Further evidence that indorenate is a 5-HT1 agonist.
    Benítez-King G; Chávez JL; Martínez I; Antón-Tay F; Hong E
    Proc West Pharmacol Soc; 1991; 34():433-7. PubMed ID: 1838609
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin-1A receptor activation in hippocampal CA1 neurons by 8-hydroxy-2-(di-n-propylamino)tetralin, 5-methoxytryptamine and 5-hydroxytryptamine.
    Wu PH; Gurevich N; Carlen PL
    Neurosci Lett; 1988 Mar; 86(1):72-6. PubMed ID: 2966313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus properties of indorenate, a serotonin agonist.
    Velázquez-Martínez DN; López Cabrera M; Sánchez H; Ramírez JI; Hong E
    J Psychiatry Neurosci; 1999 Mar; 24(2):122-30. PubMed ID: 10212554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for 5-HT1A binding sites in chick embryo brain and discrimination by 5-methoxytryptamine.
    Soblosky JS; Dills C; DuMontier G; Jeng I
    Biochem Int; 1987 May; 14(5):797-803. PubMed ID: 2970262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.
    Martínez-Mota L; Estrada-Camarena E; López-Rubalcava C
    Psychopharmacology (Berl); 2002 Dec; 165(1):60-6. PubMed ID: 12474119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of 5-HT 1A receptors after irreversible blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Bolaños FJ; Schechter LE; Laporte AM; Hamon M; Gozlan H
    Proc West Pharmacol Soc; 1991; 34():387-93. PubMed ID: 1838607
    [No Abstract]   [Full Text] [Related]  

  • 7. A C2-methylated derivative of the 5-hydroxy-tryptamine-receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH DPAT).
    Mellin C; Liu Y; Hacksell U; Björk L; Andén NE
    Acta Pharm Suec; 1987; 24(4):153-60. PubMed ID: 2964167
    [No Abstract]   [Full Text] [Related]  

  • 8. Indorenate modifies a1-adrenergic and benzodiazepine receptor binding in the rat brain: an autoradiography study.
    López-Meraz ML; Neri-Bazán L; Rocha L
    J Pharm Pharmacol; 2006 Sep; 58(9):1243-8. PubMed ID: 16945183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multiple [3H]8-hydroxy-2-(di-n-propylamino)-tetralin binding sites in rat brain: modulation by GTP and cations].
    Yokota N; Yamawaki S; Hayakawa H; Yoshida R; Sarai K
    Yakubutsu Seishin Kodo; 1989 Jun; 9(2):197-206. PubMed ID: 2530729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [125I-BH-8-MeO-N-PAT, a new ligand for the study of 5-HT1A receptors in the central nervous system].
    Ponchant M; Beaucourt JP; Vanhove A; Daval G; Vergé D; Hamon M; Gozlan H
    C R Acad Sci III; 1988; 306(4):147-52. PubMed ID: 2965963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constriction of porcine arteriovenous anastomoses by indorenate is unrelated to 5-HT1A, 5-HT1B, 5-HT1C or 5-HT1D receptor subtypes.
    Villalón CM; Bom AH; Heiligers JP; Den Boer MO; Saxena PR
    Eur J Pharmacol; 1990 Nov; 190(1-2):167-76. PubMed ID: 2076752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A; Sebben M; Bockaert J
    Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ipsapirone on the level of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in some regions of the rat brain.
    Gołembiowska K
    Pol J Pharmacol Pharm; 1989; 41(1):33-9. PubMed ID: 2479937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence for a central antihypertensive effect of indorenate.
    Hong E; Rion R; Aceves J; Benitez-King G; Anton-Tay F
    Proc West Pharmacol Soc; 1987; 30():1-3. PubMed ID: 3476964
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of sulfhydryl-modifying reagents, 3-nitro-2-pyridinesulfenyl compounds, on the coupling between inhibitory receptors and GTP-binding proteins Gi/Go in rat brain membranes.
    Kitamura Y; Imai S; Matsueda R; Nomura Y
    Mol Pharmacol; 1990 Aug; 38(2):184-91. PubMed ID: 2166901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the involvement of the 5-HT1A receptor in the anxiolytic action of indorenate and ipsapirone.
    Fernández-Guasti A; López-Rubalcava C
    Psychopharmacology (Berl); 1990; 101(3):354-8. PubMed ID: 1972996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site.
    Middlemiss DN; Fozard JR
    Eur J Pharmacol; 1983 May; 90(1):151-3. PubMed ID: 6223827
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of the intracerebroventricular administration of indorenate and fenfluramine on spontaneous behavior and food intake in rats.
    López Cabrera M; Velázquez Martínez DN; Prado R; García G; Ortiz R
    Proc West Pharmacol Soc; 1991; 34():465-8. PubMed ID: 1788330
    [No Abstract]   [Full Text] [Related]  

  • 20. MDL 73005EF: partial agonist at the 5-HT1A receptor negatively linked to adenylate cyclase.
    Cornfield LJ; Nelson DL; Taylor EW; Martin AR
    Eur J Pharmacol; 1989 Dec; 173(2-3):189-92. PubMed ID: 2560432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.